APO Research
Talk to an analyst

APO RESEARCH · REPORT

Indapamide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Indapamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchIndapamide Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Indapamide Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Indapamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indapamide Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Indapamide Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Indapamide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Indapamide include ANI Pharma, Apeloa Kangyu, Cigna, Glenmark Pharmaceuticals, Servier, Supra Chemicals, Taj Pharmaceuticals, Mylan and Shandong Yinfeida Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Indapamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Indapamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Indapamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Indapamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Indapamide Segment by Company

ANI Pharma

Apeloa Kangyu

Cigna

Glenmark Pharmaceuticals

Servier

Supra Chemicals

Taj Pharmaceuticals

Mylan

Shandong Yinfeida Pharmaceutical

Suzhou Lixinpharm

Teva

Lisheng Pharma

Indapamide Segment by Type

1.25 mg Indapamide Tablets

2.5 mg Indapamide Tablets

Indapamide Segment by Application

Diuretic

Hypertension Treatment

Other

Indapamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indapamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indapamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indapamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Indapamide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Indapamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Indapamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Indapamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Indapamide Industry Trends Table 2. Indapamide Industry Drivers Table 3. Indapamide Industry Opportunities and Challenges Table 4. Indapamide Industry Restraints Table 5. Global Indapamide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Indapamide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Indapamide Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Indapamide Sales Market Share by Manufacturers Table 9. Global Indapamide Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Indapamide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Indapamide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Indapamide Manufacturers, Product Type & Application Table 13. Global Indapamide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Indapamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1.25 mg Indapamide Tablets Table 17. Major Manufacturers of 2.5 mg Indapamide Tablets Table 18. Global Indapamide Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 19. Global Indapamide Sales by Type (2021-2026) & (K Tons) Table 20. Global Indapamide Sales by Type (2027-2032) & (K Tons) Table 21. Global Indapamide Sales Market Share by Type (2021-2026) Table 22. Global Indapamide Sales Market Share by Type (2027-2032) Table 23. Global Indapamide Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 24. Global Indapamide Revenue by Type (2021-2026) & (K Tons) Table 25. Global Indapamide Revenue by Type (2027-2032) & (K Tons) Table 26. Global Indapamide Revenue Market Share by Type (2021-2026) Table 27. Global Indapamide Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Diuretic Table 29. Major Manufacturers of Hypertension Treatment Table 30. Major Manufacturers of Other Table 31. Global Indapamide Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 32. Global Indapamide Sales by Application (2021-2026) & (K Tons) Table 33. Global Indapamide Sales by Application (2027-2032) & (K Tons) Table 34. Global Indapamide Sales Market Share by Application (2021-2026) Table 35. Global Indapamide Sales Market Share by Application (2027-2032) Table 36. Global Indapamide Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 37. Global Indapamide Revenue by Application (2021-2026) & (K Tons) Table 38. Global Indapamide Revenue by Application (2027-2032) & (K Tons) Table 39. Global Indapamide Revenue Market Share by Application (2021-2026) Table 40. Global Indapamide Revenue Market Share by Application (2027-2032) Table 41. Global Indapamide Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 42. Global Indapamide Sales by Region (2021-2026) & (K Tons) Table 43. Global Indapamide Sales Market Share by Region (2021-2026) Table 44. Global Indapamide Sales Forecasted by Region (2027-2032) & (K Tons) Table 45. Global Indapamide Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 47. North America Indapamide Sales by Country (2021-2026) & (K Tons) Table 48. North America Indapamide Sales by Country (2027-2032) & (K Tons) Table 49. Europe Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 50. Europe Indapamide Sales by Country (2021-2026) & (K Tons) Table 51. Europe Indapamide Sales by Country (2027-2032) & (K Tons) Table 52. Asia Pacific Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 53. Asia Pacific Indapamide Sales by Country (2021-2026) & (K Tons) Table 54. Asia Pacific Indapamide Sales by Country (2027-2032) & (K Tons) Table 55. South America, Middle East and Africa Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. South America, Middle East and Africa Indapamide Sales by Country (2021-2026) & (K Tons) Table 57. South America, Middle East and Africa Indapamide Sales by Country (2027-2032) & (K Tons) Table 58. Global Indapamide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Indapamide Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Indapamide Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Indapamide Revenue Market Share by Region (2021-2026) Table 62. Global Indapamide Revenue Market Share by Region (2027-2032) Table 63. ANI Pharma Company Information Table 64. ANI Pharma Business Overview Table 65. ANI Pharma Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ANI Pharma Indapamide Product Portfolio Table 67. ANI Pharma Recent Development Table 68. Apeloa Kangyu Company Information Table 69. Apeloa Kangyu Business Overview Table 70. Apeloa Kangyu Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Apeloa Kangyu Indapamide Product Portfolio Table 72. Apeloa Kangyu Recent Development Table 73. Cigna Company Information Table 74. Cigna Business Overview Table 75. Cigna Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Cigna Indapamide Product Portfolio Table 77. Cigna Recent Development Table 78. Glenmark Pharmaceuticals Company Information Table 79. Glenmark Pharmaceuticals Business Overview Table 80. Glenmark Pharmaceuticals Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Glenmark Pharmaceuticals Indapamide Product Portfolio Table 82. Glenmark Pharmaceuticals Recent Development Table 83. Servier Company Information Table 84. Servier Business Overview Table 85. Servier Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Servier Indapamide Product Portfolio Table 87. Servier Recent Development Table 88. Supra Chemicals Company Information Table 89. Supra Chemicals Business Overview Table 90. Supra Chemicals Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Supra Chemicals Indapamide Product Portfolio Table 92. Supra Chemicals Recent Development Table 93. Taj Pharmaceuticals Company Information Table 94. Taj Pharmaceuticals Business Overview Table 95. Taj Pharmaceuticals Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Taj Pharmaceuticals Indapamide Product Portfolio Table 97. Taj Pharmaceuticals Recent Development Table 98. Mylan Company Information Table 99. Mylan Business Overview Table 100. Mylan Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mylan Indapamide Product Portfolio Table 102. Mylan Recent Development Table 103. Shandong Yinfeida Pharmaceutical Company Information Table 104. Shandong Yinfeida Pharmaceutical Business Overview Table 105. Shandong Yinfeida Pharmaceutical Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio Table 107. Shandong Yinfeida Pharmaceutical Recent Development Table 108. Suzhou Lixinpharm Company Information Table 109. Suzhou Lixinpharm Business Overview Table 110. Suzhou Lixinpharm Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Suzhou Lixinpharm Indapamide Product Portfolio Table 112. Suzhou Lixinpharm Recent Development Table 113. Teva Company Information Table 114. Teva Business Overview Table 115. Teva Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Teva Indapamide Product Portfolio Table 117. Teva Recent Development Table 118. Lisheng Pharma Company Information Table 119. Lisheng Pharma Business Overview Table 120. Lisheng Pharma Indapamide Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Lisheng Pharma Indapamide Product Portfolio Table 122. Lisheng Pharma Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Indapamide Distributors List Table 126. Indapamide Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Indapamide Product Image Figure 2. Global Indapamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indapamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Indapamide Sales (2021-2032) & (K Tons) Figure 5. Global Indapamide Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Indapamide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1.25 mg Indapamide Tablets Image Figure 9. 2.5 mg Indapamide Tablets Image Figure 10. Global Indapamide Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 11. Global Indapamide Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Indapamide Sales Market Share by Type (2021-2032) Figure 13. Global Indapamide Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 14. Global Indapamide Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Indapamide Revenue Market Share by Type (2021-2032) Figure 16. Diuretic Image Figure 17. Hypertension Treatment Image Figure 18. Other Image Figure 19. Global Indapamide Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 20. Global Indapamide Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Indapamide Sales Market Share by Application (2021-2032) Figure 22. Global Indapamide Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 23. Global Indapamide Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Indapamide Revenue Market Share by Application (2021-2032) Figure 25. North America Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 26. North America Indapamide Sales Market Share by Country (2021-2032) Figure 27. U.S. Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 28. Canada Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Mexico Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Europe Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe Indapamide Sales Market Share by Country (2021-2032) Figure 32. Germany Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 33. France Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. U.K. Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. Italy Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Netherlands Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Asia Pacific Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific Indapamide Sales Market Share by Country (2021-2032) Figure 39. China Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 40. Japan Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. South Korea Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. Southeast Asia Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. India Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. Australia Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. South America, Middle East and Africa Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa Indapamide Sales Market Share by Country (2021-2032) Figure 47. Brazil Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 48. South Africa Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. Saudi Arabia Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Turkey Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Argentina Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. UAE Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. Egypt Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Chile Indapamide Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Global Indapamide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Indapamide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Indapamide Revenue (2021-2032) & (US$ Million) Figure 58. North America Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Indapamide Revenue (2021-2032) & (US$ Million) Figure 60. Europe Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Indapamide Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Indapamide Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Indapamide Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Indapamide Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 1.25 mg Indapamide Tablets
  • 2.5 mg Indapamide Tablets
Applications
  • Diuretic
  • Hypertension Treatment
  • Other
Companies covered
  • ANI Pharma
  • Apeloa Kangyu
  • Cigna
  • Glenmark Pharmaceuticals
  • Servier
  • Supra Chemicals
  • Taj Pharmaceuticals
  • Mylan
  • Shandong Yinfeida Pharmaceutical
  • Suzhou Lixinpharm
  • Teva
  • Lisheng Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Indapamide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Indapamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Indapamide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Indapamide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Indapamide Market Dynamics
  1. 2.1 Indapamide Industry Trends
  2. 2.2 Indapamide Industry Drivers
  3. 2.3 Indapamide Industry Opportunities and Challenges
  4. 2.4 Indapamide Industry Restraints
3 Indapamide Market by Manufacturers
  1. 3.1 Global Indapamide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Indapamide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Indapamide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Indapamide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Indapamide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Indapamide Manufacturers, Product Type & Application
  7. 3.7 Global Indapamide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Indapamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Indapamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Indapamide Tier 1, Tier 2, and Tier 3
4 Indapamide Market by Type
  1. 4.1 Indapamide Type Introduction
  2. 4.1.1 1.25 mg Indapamide Tablets
  3. 4.1.2 2.5 mg Indapamide Tablets
  4. 4.2 Global Indapamide Sales by Type
  5. 4.2.1 Global Indapamide Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Indapamide Sales by Type (2021-2032)
  7. 4.2.3 Global Indapamide Sales Market Share by Type (2021-2032)
  8. 4.3 Global Indapamide Revenue by Type
  9. 4.3.1 Global Indapamide Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Indapamide Revenue by Type (2021-2032)
  11. 4.3.3 Global Indapamide Revenue Market Share by Type (2021-2032)
5 Indapamide Market by Application
  1. 5.1 Indapamide Application Introduction
  2. 5.1.1 Diuretic
  3. 5.1.2 Hypertension Treatment
  4. 5.1.3 Other
  5. 5.2 Global Indapamide Sales by Application
  6. 5.2.1 Global Indapamide Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Indapamide Sales by Application (2021-2032)
  8. 5.2.3 Global Indapamide Sales Market Share by Application (2021-2032)
  9. 5.3 Global Indapamide Revenue by Application
  10. 5.3.1 Global Indapamide Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Indapamide Revenue by Application (2021-2032)
  12. 5.3.3 Global Indapamide Revenue Market Share by Application (2021-2032)
6 Global Indapamide Sales by Region
  1. 6.1 Global Indapamide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Indapamide Sales by Region (2021-2032)
  3. 6.2.1 Global Indapamide Sales by Region (2021-2026)
  4. 6.2.2 Global Indapamide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Indapamide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Indapamide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Indapamide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Indapamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Indapamide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Indapamide Revenue by Region
  1. 7.1 Global Indapamide Revenue by Region
  2. 7.1.1 Global Indapamide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Indapamide Revenue by Region (2021-2026)
  4. 7.1.3 Global Indapamide Revenue by Region (2027-2032)
  5. 7.1.4 Global Indapamide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Indapamide Revenue (2021-2032)
  8. 7.2.2 North America Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Indapamide Revenue (2021-2032)
  11. 7.3.2 Europe Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Indapamide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Indapamide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Indapamide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ANI Pharma
  2. 8.1.1 ANI Pharma Company Information
  3. 8.1.2 ANI Pharma Business Overview
  4. 8.1.3 ANI Pharma Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ANI Pharma Indapamide Product Portfolio
  6. 8.1.5 ANI Pharma Recent Developments
  7. 8.2 Apeloa Kangyu
  8. 8.2.1 Apeloa Kangyu Company Information
  9. 8.2.2 Apeloa Kangyu Business Overview
  10. 8.2.3 Apeloa Kangyu Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apeloa Kangyu Indapamide Product Portfolio
  12. 8.2.5 Apeloa Kangyu Recent Developments
  13. 8.3 Cigna
  14. 8.3.1 Cigna Company Information
  15. 8.3.2 Cigna Business Overview
  16. 8.3.3 Cigna Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cigna Indapamide Product Portfolio
  18. 8.3.5 Cigna Recent Developments
  19. 8.4 Glenmark Pharmaceuticals
  20. 8.4.1 Glenmark Pharmaceuticals Company Information
  21. 8.4.2 Glenmark Pharmaceuticals Business Overview
  22. 8.4.3 Glenmark Pharmaceuticals Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glenmark Pharmaceuticals Indapamide Product Portfolio
  24. 8.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 8.5 Servier
  26. 8.5.1 Servier Company Information
  27. 8.5.2 Servier Business Overview
  28. 8.5.3 Servier Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Servier Indapamide Product Portfolio
  30. 8.5.5 Servier Recent Developments
  31. 8.6 Supra Chemicals
  32. 8.6.1 Supra Chemicals Company Information
  33. 8.6.2 Supra Chemicals Business Overview
  34. 8.6.3 Supra Chemicals Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Supra Chemicals Indapamide Product Portfolio
  36. 8.6.5 Supra Chemicals Recent Developments
  37. 8.7 Taj Pharmaceuticals
  38. 8.7.1 Taj Pharmaceuticals Company Information
  39. 8.7.2 Taj Pharmaceuticals Business Overview
  40. 8.7.3 Taj Pharmaceuticals Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Taj Pharmaceuticals Indapamide Product Portfolio
  42. 8.7.5 Taj Pharmaceuticals Recent Developments
  43. 8.8 Mylan
  44. 8.8.1 Mylan Company Information
  45. 8.8.2 Mylan Business Overview
  46. 8.8.3 Mylan Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Indapamide Product Portfolio
  48. 8.8.5 Mylan Recent Developments
  49. 8.9 Shandong Yinfeida Pharmaceutical
  50. 8.9.1 Shandong Yinfeida Pharmaceutical Company Information
  51. 8.9.2 Shandong Yinfeida Pharmaceutical Business Overview
  52. 8.9.3 Shandong Yinfeida Pharmaceutical Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio
  54. 8.9.5 Shandong Yinfeida Pharmaceutical Recent Developments
  55. 8.10 Suzhou Lixinpharm
  56. 8.10.1 Suzhou Lixinpharm Company Information
  57. 8.10.2 Suzhou Lixinpharm Business Overview
  58. 8.10.3 Suzhou Lixinpharm Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Suzhou Lixinpharm Indapamide Product Portfolio
  60. 8.10.5 Suzhou Lixinpharm Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Teva Indapamide Product Portfolio
  66. 8.11.5 Teva Recent Developments
  67. 8.12 Lisheng Pharma
  68. 8.12.1 Lisheng Pharma Company Information
  69. 8.12.2 Lisheng Pharma Business Overview
  70. 8.12.3 Lisheng Pharma Indapamide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lisheng Pharma Indapamide Product Portfolio
  72. 8.12.5 Lisheng Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Indapamide Value Chain Analysis
  2. 9.1.1 Indapamide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Indapamide Production Mode & Process
  6. 9.2 Indapamide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Indapamide Distributors
  9. 9.2.3 Indapamide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst